ArticleHemaSphere2025

High-dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited-stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial.

Gotti Manuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.